MAHLY
Price
$16.48
Change
-$0.89 (-5.12%)
Updated
Jul 21 closing price
Capitalization
3.69B
MEPDF
Price
$15.90
Change
-$0.35 (-2.15%)
Updated
Jul 7 closing price
Capitalization
3.69B
Interact to see
Advertisement

MAHLY vs MEPDF

Header iconMAHLY vs MEPDF Comparison
Open Charts MAHLY vs MEPDFBanner chart's image
Medipal Holdings
Price$16.48
Change-$0.89 (-5.12%)
Volume$483
Capitalization3.69B
Medipal Holdings
Price$15.90
Change-$0.35 (-2.15%)
Volume$100
Capitalization3.69B
MAHLY vs MEPDF Comparison Chart in %
Loading...
MAHLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MEPDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MAHLY vs. MEPDF commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MAHLY is a Hold and MEPDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (MAHLY: $16.48 vs. MEPDF: $15.90)
Brand notoriety: MAHLY and MEPDF are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: MAHLY: 19% vs. MEPDF: 53%
Market capitalization -- MAHLY: $3.69B vs. MEPDF: $3.69B
MAHLY [@Medical Distributors] is valued at $3.69B. MEPDF’s [@Medical Distributors] market capitalization is $3.69B. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MAHLY’s FA Score shows that 0 FA rating(s) are green whileMEPDF’s FA Score has 0 green FA rating(s).

  • MAHLY’s FA Score: 0 green, 5 red.
  • MEPDF’s FA Score: 0 green, 5 red.
According to our system of comparison, MEPDF is a better buy in the long-term than MAHLY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MAHLY’s TA Score shows that 4 TA indicator(s) are bullish while MEPDF’s TA Score has 3 bullish TA indicator(s).

  • MAHLY’s TA Score: 4 bullish, 4 bearish.
  • MEPDF’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, both MAHLY and MEPDF are a good buy in the short-term.

Price Growth

MAHLY (@Medical Distributors) experienced а -5.15% price change this week, while MEPDF (@Medical Distributors) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +3.49%. For the same industry, the average monthly price growth was +10.91%, and the average quarterly price growth was +3.82%.

Industries' Descriptions

@Medical Distributors (+3.49% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MAHLY($3.69B) and MEPDF($3.69B) have the same market capitalization . MAHLY has higher P/E ratio than MEPDF: MAHLY (13.48) vs MEPDF (12.29). MEPDF YTD gains are higher at: 20.091 vs. MAHLY (2.488). MAHLY (74B) and MEPDF (74B) have comparable annual earnings (EBITDA) . MAHLY (252B) and MEPDF (252B) have equal amount of cash in the bank . MAHLY (30B) and MEPDF (30B) have identical debt. MAHLY (3.35T) and MEPDF (3.35T) have equivalent revenues.
MAHLYMEPDFMAHLY / MEPDF
Capitalization3.69B3.69B100%
EBITDA74B74B100%
Gain YTD2.48820.09112%
P/E Ratio13.4812.29110%
Revenue3.35T3.35T100%
Total Cash252B252B100%
Total Debt30B30B100%
FUNDAMENTALS RATINGS
MAHLY vs MEPDF: Fundamental Ratings
MAHLY
MEPDF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
87
Overvalued
PROFIT vs RISK RATING
1..100
10049
SMR RATING
1..100
4141
PRICE GROWTH RATING
1..100
5051
P/E GROWTH RATING
1..100
4737
SEASONALITY SCORE
1..100
55n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MEPDF's Valuation (87) in the null industry is in the same range as MAHLY (88). This means that MEPDF’s stock grew similarly to MAHLY’s over the last 12 months.

MEPDF's Profit vs Risk Rating (49) in the null industry is somewhat better than the same rating for MAHLY (100). This means that MEPDF’s stock grew somewhat faster than MAHLY’s over the last 12 months.

MEPDF's SMR Rating (41) in the null industry is in the same range as MAHLY (41). This means that MEPDF’s stock grew similarly to MAHLY’s over the last 12 months.

MAHLY's Price Growth Rating (50) in the null industry is in the same range as MEPDF (51). This means that MAHLY’s stock grew similarly to MEPDF’s over the last 12 months.

MEPDF's P/E Growth Rating (37) in the null industry is in the same range as MAHLY (47). This means that MEPDF’s stock grew similarly to MAHLY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MAHLYMEPDF
RSI
ODDS (%)
Bearish Trend 5 days ago
43%
Bullish Trend 5 days ago
17%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
35%
N/A
Momentum
ODDS (%)
Bullish Trend 3 days ago
33%
Bullish Trend 3 days ago
25%
MACD
ODDS (%)
Bullish Trend 3 days ago
24%
Bullish Trend 3 days ago
8%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
36%
Bullish Trend 3 days ago
16%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
32%
Bearish Trend 3 days ago
9%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
42%
N/A
Aroon
ODDS (%)
Bearish Trend 5 days ago
35%
Bearish Trend 3 days ago
16%
View a ticker or compare two or three
Interact to see
Advertisement
MAHLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MEPDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
YANG26.460.58
+2.24%
Direxion Daily FTSE China Bear 3X ETF
FJUL53.100.15
+0.28%
FT Vest US Equity Buffer ETF Jul
NAUG27.94N/A
N/A
Innovator Growth-100 Pwr Buffr ETF - Aug
QLVD31.26N/A
N/A
FlexShares Dev Mks ex-US Qual Lw Vol ETF
IRET19.18-0.13
-0.67%
iREIT MarketVector Quality REIT Idx ETF

MAHLY and

Correlation & Price change

A.I.dvisor tells us that MAHLY and MEPDF have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MAHLY and MEPDF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MAHLY
1D Price
Change %
MAHLY100%
N/A
MEPDF - MAHLY
9%
Poorly correlated
N/A
ZYXI - MAHLY
5%
Poorly correlated
+1.98%
ARRJF - MAHLY
2%
Poorly correlated
N/A
SHPMF - MAHLY
2%
Poorly correlated
N/A
NSVGF - MAHLY
2%
Poorly correlated
N/A
More

MEPDF and

Correlation & Price change

A.I.dvisor tells us that MEPDF and COSM have been poorly correlated (+12% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MEPDF and COSM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEPDF
1D Price
Change %
MEPDF100%
N/A
COSM - MEPDF
12%
Poorly correlated
N/A
MAHLY - MEPDF
9%
Poorly correlated
N/A
SHPMF - MEPDF
2%
Poorly correlated
N/A
PDRX - MEPDF
0%
Poorly correlated
N/A
ARRJF - MEPDF
0%
Poorly correlated
N/A
More